Dare Bioscience is a biotechnology business based in the US. Dare Bioscience shares (DARE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.98 – a decrease of 0.17% over the previous week. Dare Bioscience employs 21 staff and has a trailing 12-month revenue of around $9,784.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $2.98 |
|---|---|
| 52-week range | $2.67 - $7.56 |
| 50-day moving average | $2.96 |
| 200-day moving average | $3.29 |
| Wall St. target price | $13.33 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.48 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.93 from 2025-05-01
| 1 week (2025-04-25) | -1.84% |
|---|---|
| 1 month (2025-04-03) | 2.93 |
| 3 months (2025-02-03) | -6.98% |
| 6 months (2024-11-01) | -29.57% |
| 1 year (2024-05-03) | 841.52% |
|---|---|
| 2 years (2023-05-03) | -75.17% |
| 3 years (2022-05-03) | 13.8 |
| 5 years (2020-05-01) | 13.08 |
| Revenue TTM | $9,784 |
|---|---|
| Operating margin TTM | 8465.75% |
| Gross profit TTM | $-14,295,424 |
| Return on assets TTM | -67.57% |
| Return on equity TTM | -994.69% |
| Profit margin | 0% |
| Book value | $-0.69 |
| Market Capitalization | $26.4 million |
TTM: trailing 12 months
We're not expecting Dare Bioscience to pay a dividend over the next 12 months.
Dare Bioscience's shares were split on a 1:12 basis on 30 June 2024 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Dare Bioscience shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Dare Bioscience shares which in turn could have impacted Dare Bioscience's share price.
Over the last 12 months, Dare Bioscience's shares have ranged in value from as little as $2.6703 up to $7.56. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dare Bioscience's is 1.343. This would suggest that Dare Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Daré Bioscience, Inc. , a biopharmaceutical company, develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert for the treatment of cervical intraepithelial neoplasia and other human papillomavirus related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; and DARE-GML, a multi-target antimicrobial agent. Daré Bioscience, Inc.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Fidelity is best for its extensive tools and resources, while Robinhood is a popular choice for its simple, easy-to-use platform.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .